The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mycoses


High impact information on Mycoses


Chemical compound and disease context of Mycoses


Biological context of Mycoses


Anatomical context of Mycoses


Gene context of Mycoses

  • This case should alert clinicians to the increased incidence of pulmonary mycoses in patients receiving anti-TNF-alpha therapy [23].
  • At the same dilution, no reaction was detected with sera from normal individuals and from patients with other mycoses [24].
  • For these reasons AME has been porposed as an alternative to amphotericin B in the therapy of deep mycoses [25].
  • However, only 2.8% (3 of 109) of the serum samples from patients with other mycoses and nonmycotic infections showed IgM adsorption to the 120-kDa TP-Ag as detected by the ELISA, while 21.1% (23 of 109) showed IgM adsorption to the 110-kDa TP-Ag [26].
  • This study provides preliminary evidence that ABCD is effective in treating invasive mycoses and lacks the dose-limiting nephrotoxicity of CAB [27].

Analytical, diagnostic and therapeutic context of Mycoses


  1. Oral azole drugs as systemic antifungal therapy. Como, J.A., Dismukes, W.E. N. Engl. J. Med. (1994) [Pubmed]
  2. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Galgiani, J.N., Catanzaro, A., Cloud, G.A., Johnson, R.H., Williams, P.L., Mirels, L.F., Nassar, F., Lutz, J.E., Stevens, D.A., Sharkey, P.K., Singh, V.R., Larsen, R.A., Delgado, K.L., Flanigan, C., Rinaldi, M.G. Ann. Intern. Med. (2000) [Pubmed]
  3. Alopecia associated with fluconazole therapy. Pappas, P.G., Kauffman, C.A., Perfect, J., Johnson, P.C., McKinsey, D.S., Bamberger, D.M., Hamill, R., Sharkey, P.K., Chapman, S.W., Sobel, J.D. Ann. Intern. Med. (1995) [Pubmed]
  4. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Denning, D.W., Lee, J.Y., Hostetler, J.S., Pappas, P., Kauffman, C.A., Dewsnup, D.H., Galgiani, J.N., Graybill, J.R., Sugar, A.M., Catanzaro, A. Am. J. Med. (1994) [Pubmed]
  5. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Barbour, G.L., Straub, K.D., O'Neal, B.L., Leatherman, J.W. Arch. Intern. Med. (1979) [Pubmed]
  6. Differences in the recognition of glucan elicitor signals between rice and soybean: beta-glucan fragments from the rice blast disease fungus Pyricularia oryzae that elicit phytoalexin biosynthesis in suspension-cultured rice cells. Yamaguchi, T., Yamada, A., Hong, N., Ogawa, T., Ishii, T., Shibuya, N. Plant Cell (2000) [Pubmed]
  7. Ketoconazole in systemic mycoses. Hoeprich, P.D. Ann. Intern. Med. (1983) [Pubmed]
  8. Current perspectives on ophthalmic mycoses. Thomas, P.A. Clin. Microbiol. Rev. (2003) [Pubmed]
  9. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Podust, L.M., Poulos, T.L., Waterman, M.R. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  10. Compounds active against cell walls of medically important fungi. Hector, R.F. Clin. Microbiol. Rev. (1993) [Pubmed]
  11. Ketoconazole blocks testosterone synthesis. Pont, A., Williams, P.L., Azhar, S., Reitz, R.E., Bochra, C., Smith, E.R., Stevens, D.A. Arch. Intern. Med. (1982) [Pubmed]
  12. Terbinafine. An update of its use in superficial mycoses. McClellan, K.J., Wiseman, L.R., Markham, A. Drugs (1999) [Pubmed]
  13. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. Debruyne, D. Clinical pharmacokinetics. (1997) [Pubmed]
  14. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses. Saint-Julien, L., Joly, V., Seman, M., Carbon, C., Yeni, P. Antimicrob. Agents Chemother. (1992) [Pubmed]
  15. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Goa, K.L., Barradell, L.B. Drugs (1995) [Pubmed]
  16. Production of culture filtrates of Sporothrix schenckii in diverse culture media. Mendoza, M., Díaz, A.M., Hung, M.B., Zambrano, E.A., Díaz, E., De Albornoz, M.C. Med. Mycol. (2002) [Pubmed]
  17. Sertaconazole in the treatment of mycoses: from dermatology to gynecology. Torres, J., Márquez, M., Camps, F. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. (2000) [Pubmed]
  18. Epidemiology of digestive tract mycoses in immunocompromised patients--a review. Farina, C., Castelli, F., Carosi, G. Eur. J. Epidemiol. (1990) [Pubmed]
  19. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture. Larson, S.M. Radiology. (1987) [Pubmed]
  20. Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses. Persson, U., Tennvall, G.R., Andersson, S., Tyden, G., Wettermark, B. PharmacoEconomics. (1992) [Pubmed]
  21. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Giordani, R., Regli, P., Kaloustian, J., Mikaïl, C., Abou, L., Portugal, H. Phytotherapy research : PTR. (2004) [Pubmed]
  22. Laboratory evaluation of new antifungal agents against rare and refractory mycoses. Sutton, D.A. Curr. Opin. Infect. Dis. (2002) [Pubmed]
  23. Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Hage, C.A., Wood, K.L., Winer-Muram, H.T., Wilson, S.J., Sarosi, G., Knox, K.S. Chest (2003) [Pubmed]
  24. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Puccia, R., Schenkman, S., Gorin, P.A., Travassos, L.R. Infect. Immun. (1986) [Pubmed]
  25. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. Gadebusch, H.H., Pansy, F., Klepner, C., Schwind, R. J. Infect. Dis. (1976) [Pubmed]
  26. Antigen complex of Coccidioides immitis which elicits a precipitin antibody response in patients. Cole, G.T., Kruse, D., Seshan, K.R. Infect. Immun. (1991) [Pubmed]
  27. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Oppenheim, B.A., Herbrecht, R., Kusne, S. Clin. Infect. Dis. (1995) [Pubmed]
  28. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Drouhet, E., Dupont, B. Am. J. Med. (1983) [Pubmed]
  29. Epidemiology of systemic mycoses among renal-transplant recipients in India. Tharayil John, G., Shankar, V., Talaulikar, G., Mathews, M.S., Abraham Abraham, M., Punnakuzhathil Thomas, P., Korula Jacob, C. Transplantation (2003) [Pubmed]
  30. Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards. Law, D., Moore, C.B., Denning, D.W. Antimicrob. Agents Chemother. (1994) [Pubmed]
  31. High-dose itraconazole in the treatment of severe mycoses. Sharkey, P.K., Rinaldi, M.G., Dunn, J.F., Hardin, T.C., Fetchick, R.J., Graybill, J.R. Antimicrob. Agents Chemother. (1991) [Pubmed]
  32. Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections. Odds, F.C., Oris, M., Van Dorsselaer, P., Van Gerven, F. Antimicrob. Agents Chemother. (2000) [Pubmed]
WikiGenes - Universities